Printer Friendly

BIOPLASTY ANNOUNCES RESIGNATION OF CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD

 BIOPLASTY ANNOUNCES RESIGNATION OF CHIEF EXECUTIVE
 OFFICER AND CHAIRMAN OF THE BOARD
 ST. PAUL, Minn., Feb. 25 /PRNewswire/ -- Bioplasty, Inc. (NASDAQ: BIOP) announced today the resignation of Arthur A. Beisang as chief executive officer and chairman of the board of Bioplasty, Inc. Beisang will be devoting his time and efforts to Uroplasty, Inc., the company formed for the purpose of focusing on the urological business in the medical market.
 The board of directors has appointed Daniel G. Holman to succeed Beisang as chairman of the board, while Timothy P. Lawin was appointed to the position of chief executive officer, in addition to his current role as president of Bioplasty.
 Bioplasty, Inc. has more than 20 years of experience in the development, manufacturing and marketing of plastic surgery products worldwide. Bioplasty's stock is currently traded on the NASDAQ National Market System under the symbol "BIOP."
 -0- 2/25/92
 /CONTACT: Timothy P. Lawin, president of Bioplasty, 612-636-4112/
 (BIOP) CO: Bioplasty, Inc. ST: Minnesota IN: MTC SU: PER


AL -- MN010 -- 2560 02/25/92 17:14 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 25, 1992
Words:175
Previous Article:CONTINUUM ANNOUNCES COGEN LICENSE IN EUROPE
Next Article:NEIC AND MCI ANNOUNCE NEIC-MAIL AND NEIC-FAX MAIL FOR THE HEALTHCARE INDUSTRY
Topics:


Related Articles
BIOPLASTY ANNOUNCES FIRST QUARTER OPERATING RESULTS
BIOPLASTY ANNOUNCES APPOINTMENT OF LINDA ALEXANDER TO THE POSITION OF DIRECTOR OF REGULATORY AFFAIRS
BIOPLASTY LICENSES SYNTHETIC WOUND CARE DRESSING
BIOPLASTY ANNOUNCES SECOND QUARTER RESULTS OF OPERATIONS
UROPLASTY ANNOUNCES APPOINTMENT OF PRESIDENT AND CHIEF EXECUTIVE OFFICER
BIOPLASTY AGREES TO PROPOSED SETTLEMENT OF SHAREHOLDERS' SUIT
UROPLASTY ANNOUNCES APPOINTMENT OF PRESIDENT
BIOPLASTY SETTLES PATENT INFRINGEMENT SUIT
BIOPLASTY, INC. ANNOUNCES PROHIBITION OF SPIN OFF RECOMMENDED
BIOPLASTY, INC. ANNOUNCES RESIGNATION OF PRESIDENT AND CHIEF EXECUTIVE OFFICER

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters